medigraphic.com
Academia Mexicana de Neurología, A.C.

2019, Number 3

<< Back Next >>

Rev Mex Neuroci 2019; 20 (3)

Incidence rates of Parkinson’s disease in Mexico: Analysis of 2014-2017 statistics

Rodríguez-Violante M, Velásquez-Pérez L, Cervantes-Arriaga A

Language: English
References: 22
Page: 136-140
PDF size: 108.57 Kb.


ABSTRACT

Objective: The objective of this study was to estimate and analyze the incidence and incidence rates of Parkinson’s disease (PD) in Mexico. Methods: Data on new cases of PD from January 2014 to December 2017 were extracted from the electronic Morbidity Annals and Epidemiological Bulletin published by the Secretary of Health. Crude and age-standardized incidence and incidence rate were calculated and compared with reports from other countries. Results: The overall incidence rate for the 2014-2017 period was 37.92/100,000 (incidence density of 9.48/100,000 person-years). The incidence rate in the 65+ population was 313.94/100,000. The incidence rate was higher in men than in women (42.22 vs. 34.78/100,000, respectively). Conclusion: The incidence rate in Mexican population increases with age, and it is slightly more frequent in men but is lower in comparison to developed countries. Differences in incidence rates between developed and underdeveloped countries merit further studies.


REFERENCES

  1. Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2014;29:1583-90.

  2. Elbaz A, Carcaillon L, Kab S, Moisan F. Epidemiology of Parkinson’s disease. Rev Neurol (Paris). 2016;172:14-26.

  3. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68:384-6.

  4. Rossi A, Berger K, Chen H, et al. Projection of the prevalence of Parkinson’s disease in the coming decades: revisited. Mov Disord. 2018;33:156‑9.

  5. Moreno-Estrada A, Gignoux CR, Fernández-López JC, et al. Human genetics. The genetics of Mexico recapitulates native American substructure and affects biomedical traits. Science. 2014;344:1280-5.

  6. Secretaría de Salud. Anuarios de Morbilidad. Dirección General de Epidemiología; 2018. Available from: http://www.epidemiologia.salud.gob. mx/anuario/html/anuarios.html. [Last accessed on 2018 Mar 08].

  7. Matus CR, Herrera AR. Boletín Epidemiológico, Sistema Nacional de Vigilancia Epidemiológica Sistema Único de Información. Secretaría de Salud; 2017. Available from: https://www.gob.mx/salud/acciones-y-programas/ direccion-general-de-epidemiologia-boletin-epidemiologico. [Last accessed on 2018 Mar 08].

  8. CONAPO. Proyecciones de la Población 2010-2050; 2018. Available from: http://www.conapo.gob.mx/es/CONAPO/Proyecciones. [Last accessed on 2018 Mar 08].

  9. Fay MP, Tiwari RC, Feuer EJ, Zou Z. Estimating average annual percent change for disease rates without assuming constant change. Biometrics. 2006;62:847-54.

  10. Blin P, Dureau-Pournin C, Foubert-Samier A, et al. Parkinson’s disease incidence and prevalence assessment in France using the national healthcare insurance database. Eur J Neurol. 2015;22:464-71.

  11. Enders D, Balzer-Geldsetzer M, Riedel O, et al. Prevalence, duration and severity of Parkinson‘s disease in germany: a combined meta-analysis from literature data and outpatient samples. Eur Neurol. 2017;78:128-36.

  12. Caslake R, Taylor K, Scott N, et al. Age-, gender-, and socioeconomic status-specific incidence of Parkinson’s disease and parkinsonism in Northeast Scotland: the PINE study. Parkinsonism Relat Disord. 2013; 19:515-21.

  13. Duncan GW, Khoo TK, Coleman SY, et al. The incidence of Parkinson’s disease in the North-East of England. Age Ageing. 2014;43:257-63.

  14. Ma CL, Su L, Xie JJ, et al. The prevalence and incidence of Parkinson’s disease in China: a systematic review and meta-analysis. J Neural Transm (Vienna). 2014;121:123-34.

  15. Allyson Jones C, Wayne Martin WR, Wieler M, King-Jesso P, Voaklander DC. Incidence and mortality of Parkinson’s disease in older Canadians. Parkinsonism Relat Disord. 2012;18:327-31.

  16. Gourie-Devi M. Epidemiology of neurological disorders in India: review of background, prevalence and incidence of epilepsy, stroke, Parkinson’s disease and tremors. Neurol India. 2014;62:588-98.

  17. Bauso DJ, Tartari JP, Stefani CV, et al. Incidence and prevalence of Parkinson’s disease in Buenos Aires city, Argentina. Eur J Neurol. 2012; 19:1108-13.

  18. de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525-35.

  19. Gordon PH, Mehal JM, Holman RC, et al. Incidence and prevalence of Parkinson’s disease among Navajo people living in the Navajo nation. Mov Disord. 2015;30:714-20.

  20. Ylikotila P, Tiirikka T, Moilanen JS, et al. Epidemiology of early-onset Parkinson’s disease in Finland. Parkinsonism Relat Disord. 2015;21938‑42.

  21. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Time trends in the incidence of Parkinson disease. JAMA Neurol. 2016;73:981-9.

  22. Horsfall L, Petersen I, Walters K, Schrag A. Time trends in incidence of Parkinson’s disease diagnosis in UK primary care. J Neurol. 2013;260: 1351-7.




2020     |     www.medigraphic.com